---
title: "Savaria (SIS) Receives a Buy from Stifel Nicolaus"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284817763.md"
description: "In a recent report, Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Savaria (SIS) with a price target of C$35.00. The analyst consensus for Savaria is a Strong Buy, with an average price target of C$34.20. Keywood focuses on the Healthcare sector and has an average return of -1.6% with a 50.73% success rate on his stock recommendations."
datetime: "2026-04-30T18:05:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284817763.md)
  - [en](https://longbridge.com/en/news/284817763.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284817763.md)
---

# Savaria (SIS) Receives a Buy from Stifel Nicolaus

In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Savaria, with a price target of C$35.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, NervGen Pharma, and HEALWELL AI. According to TipRanks, Keywood has an average return of \-1.6% and a 50.73% success rate on recommended stocks.

Currently, the analyst consensus on Savaria is a Strong Buy with an average price target of C$34.20.

### Related Stocks

- [SVRA.US](https://longbridge.com/en/quote/SVRA.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [NGEN.US](https://longbridge.com/en/quote/NGEN.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [LifeSci Capital Keeps Their Buy Rating on Savara (SVRA)](https://longbridge.com/en/news/286648897.md)
- [Pizza Pizza Royalty slashes monthly dividend by 12.9% to CAD 0.0675 a share](https://longbridge.com/en/news/286714154.md)
- [Stifel Just Raised Its Price Target on Palo Alto Networks. Here's Why.](https://longbridge.com/en/news/287118503.md)
- [Virtuix Expands Into AI-Assisted Neurodivergent Therapy Through Rutgers University Collaboration | VTIX Stock News](https://longbridge.com/en/news/287075316.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)